B
인바디
041830KOSDAQ의료용 기기 제조업55.0 / 100
Reference Date: 2026-07-24
Financial Score21.5 / 40
News Sentiment12.5 / 25
Momentum11.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but Operating Profit is on a declining trend. Rose 6.0% over the past month, and news sentiment is neutral.
Company InformationBased on 2025 Annual Report
Business Overview
InBody is a global medical equipment manufacturer established in 1996, specializing in body composition analyzers, automatic blood pressure monitors, and home-use body composition analyzers. With 83% of sales generated overseas, the company achieved a 14.4% revenue increase to 233.9 billion won in 2025.
Number of Employees
370people
Average Salary
52.8M KRW
Score Calculation Basis
Detailed Financial Score
PER
20.26Industry Average 20.043.0Point
Higher than industry avg (caution)
PBR
2.07Industry Average 1.141.0Point
1.8x industry avg (risky)
ROE
10.10Industry Average 8.004.0Point
In line with industry avg
Debt Ratio
2.62Industry Average 11.658.0Point
Half of industry avg (excellent)
Trend 2023~20255.5 / 10 points
Revenue Growth Rate
2.5 / 3
Avg ▲17.2% (2-year basis)
Operating Profit Growth Rate
0.5 / 3
Avg ▼2.1% (2-year basis)
ROE Trend
2.5 / 4
Avg ROE 12.8% (declining, 3yr)
Detailed News Sentiment
1 totalPositive 0Neutral 1Negative 0Average Sentiment Score 50
- NeutralKAIST 신임 총장에 배충식 교수…"AI 시대 역할 정할 것"(종합)
KAIST 신임 총장 선임 소식은 KAIST 자체에 긍정적 영향을 미칠 수 있으나, 인바디 주식에 직접적인 영향은 제한적입니다.
Detailed Momentum
52-week position6.0Point
52w upper range (66%)
Current 49,100Won52-week high 62,00052-week low 23,400
1-month return4.0Point
1m +6.05% (slight rise)
Volume trend1.0Point
Volume dry-up
Detailed Disclosure
2 totalPositive 0Neutral 2Negative 0
- Neutral주식등의대량보유상황보고서(일반)2026-07-03
- Neutral주식등의대량보유상황보고서(일반)2026-06-26